Skip to content

GENERIS - FARMACÊUTICA, S.A. — EU public contracts

GENERIS - FARMACÊUTICA, S.A. (Portugal) has won 5 public contracts worth undisclosed value in the EU in the last 12 months.

5 awardsPortugal

Categories

General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents: 3Medicinal products for the nervous system: 2

Awarded contracts

DateBuyerSubjectValueView on TED
21 Oct 2025Unidade Local de Saúde Santa Maria, E.P.E.Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2025/1303- ENTECAVIR [0.5 MG CÁP/COMP]—
21 Oct 2025Unidade Local de Saúde Santa Maria, E.P.E.Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2025/1303- ENTECAVIR [0.5 MG CÁP/COMP]-I—
21 Oct 2025Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Medicinal products for the nervous system – 2023/0436-RILUZOL [50 MG CÁP/COMP]—
21 Oct 2025Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Medicinal products for the nervous system – 2023/0436-RILUZOL [50 MG CÁP/COMP]—
21 Oct 2025Unidade Local de Saúde Santa Maria, E.P.E.Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2025/1303- ENTECAVIR [0.5 MG CÁP/COMP]—

See open tenders that fit a company like this

Licitora matches EU public tenders to your company profile every morning. Companies like GENERIS - FARMACÊUTICA, S.A. can save hours of manual search.